Objective: To evaluate the safety and reactogenicity of a reduced-antigen-content combined
Diphtheria-Tetanus-Acellular Pertussis (dTpa) vaccine in Indian pre-school children …

A trial to compare the reactogenicity and immunogenicity of a reduced antigen content
diphtheria–tetanus–acellular pertussis (dTpa) vaccine with diphtheria–tetanus–whole-cell …

Background. The recent introduction of acellular pertussis vaccines (Pa) offers the possibility
of booster doses in older children and adults. This can be conveniently accomplished by …

Objective: To establish safety, immunogenicity, and batch stability of a reformulated whole
cell pertussis based diphtheria‐tetanus‐whole cell pertussis (DTP) vaccine (nDTPw) …

The present study was undertaken to compare the immunogenicity and reactogenicity of two
diphtheria-tetanus-whole cell pertussis (DTwP) vaccines administered to Iranian preschool …

The objective of this study was to assess and compare the reactogenicity of GlaxoSmithKline
(GSK) Biologicals' diphtheria-tetanus-tricomponent acellular pertussis vaccine (DTPa) and …

PURPOSE: Disease caused by Bordetella pertussis is increasingly being identified among
older children and adults in immunized populations, indicating a waning of the vaccine …

Booster vaccination with a reduced-antigen-content dTpa, pediatric DTPa or adult Td
vaccine in DTPa-primed children aged 4-6 years was evaluated. Immunogenicity and CMI …

Pertussis continues to circulate in Chinese communities and older children, adolescents and
adults are sources of infection for unprotected infants. Two studies conducted in Jiangsu …

In two double-blind, randomized, comparative studies involving a total of 218 children, an
acellular pertussis (DTPa) vaccine containing diphtheria and tetanus toxoids and pertussis …